• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型细菌拓扑异构酶抑制剂作用靶点——DNA促旋酶的结构研究

Structural Aspects of DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors.

作者信息

Kokot Maja, Hrast Rambaher Martina, Feng Lipeng, Mitchenall Lesley A, Lawson David M, Maxwell Anthony, Parish Tanya, Minovski Nikola, Anderluh Marko

机构信息

Theory Department, Laboratory for Cheminformatics, National Institute of Chemistry, Hajdrihova 19, 1001 Ljubljana, Slovenia.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.

出版信息

ACS Med Chem Lett. 2024 Nov 22;15(12):2164-2170. doi: 10.1021/acsmedchemlett.4c00447. eCollection 2024 Dec 12.

DOI:10.1021/acsmedchemlett.4c00447
PMID:39691510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11647683/
Abstract

In this Letter, we present a small series of novel bacterial topoisomerase inhibitors (NTBIs) that exhibit both potent inhibition of DNA gyrase and potent antimycobacterial activity. The disclosed crystal structure of DNA gyrase in complex with DNA and compound from this NBTI series reveals the binding mode of an NBTI in the GyrA binding pocket and confirms the presence and importance of halogen bonding for the excellent on-target potency. In addition, we have shown that compound is a promising DNA gyrase inhibitor, with an IC for gyrase of 0.096 μM, and it has potent activity against , with an IC of 0.165 μM.

摘要

在本信函中，我们展示了一小系列新型细菌拓扑异构酶抑制剂（NTBIs），它们对DNA促旋酶具有强效抑制作用且具备强效抗分枝杆菌活性。所披露的该NTBI系列中与DNA及化合物形成复合物的DNA促旋酶晶体结构揭示了一种NTBI在GyrA结合口袋中的结合模式，并证实了卤键对于出色的靶向活性的存在及重要性。此外，我们已表明该化合物是一种有前景的DNA促旋酶抑制剂，其对促旋酶的IC50为0.096 μM，并且它对[具体细菌名称未给出]具有强效活性，IC50为0.165 μM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/bbacc461bca9/ml4c00447_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/d41c67eef96b/ml4c00447_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/8a62a0419791/ml4c00447_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/62f2dd1dc21c/ml4c00447_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/bbacc461bca9/ml4c00447_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/d41c67eef96b/ml4c00447_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/8a62a0419791/ml4c00447_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/62f2dd1dc21c/ml4c00447_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/567d/11647683/bbacc461bca9/ml4c00447_0004.jpg

相似文献

1
Structural Aspects of DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors.新型细菌拓扑异构酶抑制剂作用靶点——DNA促旋酶的结构研究
ACS Med Chem Lett. 2024 Nov 22;15(12):2164-2170. doi: 10.1021/acsmedchemlett.4c00447. eCollection 2024 Dec 12.
2
Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria.窄谱拓扑异构酶靶向抗菌药物的开发用于抗分枝杆菌。
Eur J Med Chem. 2024 Oct 5;276:116693. doi: 10.1016/j.ejmech.2024.116693. Epub 2024 Jul 19.
3
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.结核分枝杆菌 NBTI DNA 拓扑异构酶抑制剂对脓肿分枝杆菌有效。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0151421. doi: 10.1128/AAC.01514-21. Epub 2021 Oct 4.
4
Bioisosteric Design Identifies Inhibitors of DNA Gyrase ATPase Activity.生物等排设计鉴定 DNA 拓扑异构酶 ATP 酶活性抑制剂。
J Chem Inf Model. 2023 May 8;63(9):2707-2718. doi: 10.1021/acs.jcim.2c01376. Epub 2023 Apr 19.
5
Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.结核分枝杆菌DNA回旋酶作为药物研发靶点
Infect Disord Drug Targets. 2007 Jun;7(2):159-68. doi: 10.2174/187152607781001763.
6
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.螺吡喃并嘧啶酮类 DNA 拓扑异构酶抑制剂具有强大且选择性的抗结核活性。
J Med Chem. 2022 May 12;65(9):6903-6925. doi: 10.1021/acs.jmedchem.2c00266. Epub 2022 May 2.
7
Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions.利用NBTI抗菌剂探索靶向细菌II型拓扑异构酶的替代途径：超越卤键相互作用
Antibiotics (Basel). 2023 May 18;12(5):930. doi: 10.3390/antibiotics12050930.
8
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.结核分枝杆菌DNA回旋酶：与喹诺酮类药物的相互作用及其与抗分枝杆菌药物活性的相关性。
Antimicrob Agents Chemother. 2004 Apr;48(4):1281-8. doi: 10.1128/AAC.48.4.1281-1288.2004.
9
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.苯并噻嗪酮 - 哌嗪衍生物作为高效的结核分枝杆菌DNA回旋酶抑制剂
Int J Mycobacteriol. 2015 Jun;4(2):104-15. doi: 10.1016/j.ijmyco.2015.02.002. Epub 2015 Mar 26.
10
Mechanistic and Structural Basis for the Actions of the Antibacterial Gepotidacin against Staphylococcus aureus Gyrase.抗菌药物格帕沙星作用于金黄色葡萄球菌促旋酶的作用机制及结构基础
ACS Infect Dis. 2019 Apr 12;5(4):570-581. doi: 10.1021/acsinfecdis.8b00315. Epub 2019 Feb 28.

引用本文的文献

1
Design, Synthesis, and In Vitro Evaluation of 4-(Arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: Exploring Their Potential Against .4-(芳基硫属元素甲基)-1H-1,2,3-三唑-1-基-甲萘醌的设计、合成及体外评价：探索其对……的潜力
Pharmaceuticals (Basel). 2025 May 26;18(6):797. doi: 10.3390/ph18060797.
2
Structural and Mechanistic Insights into Atypical Bacterial Topoisomerase Inhibitors.非典型细菌拓扑异构酶抑制剂的结构与作用机制洞察
ACS Med Chem Lett. 2025 Apr 1;16(4):660-667. doi: 10.1021/acsmedchemlett.5c00060. eCollection 2025 Apr 10.

本文引用的文献

1
Molecular mechanism of a triazole-containing inhibitor of DNA gyrase.一种含三唑的DNA促旋酶抑制剂的分子机制
iScience. 2024 Sep 16;27(10):110967. doi: 10.1016/j.isci.2024.110967. eCollection 2024 Oct 18.
2
and Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections.且格帕沙星对耐药分枝杆菌感染的活性。
Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0056422. doi: 10.1128/aac.00564-22. Epub 2022 Nov 29.
3
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV.
新型细菌拓扑异构酶抑制剂的结构特征决定了它们对拓扑异构酶 IV 的活性。
J Med Chem. 2022 May 12;65(9):6431-6440. doi: 10.1021/acs.jmedchem.2c00039. Epub 2022 May 3.
4
Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity.具有增强的分叉卤键倾向的结构优化的强效双靶点NBTI抗菌剂。
ACS Med Chem Lett. 2021 Aug 16;12(9):1478-1485. doi: 10.1021/acsmedchemlett.1c00345. eCollection 2021 Sep 9.
5
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds.强效 DNA 拓扑异构酶抑制剂通过对称分叉的卤键不对称地结合其靶标。
Nat Commun. 2021 Jan 8;12(1):150. doi: 10.1038/s41467-020-20405-8.
6
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.喹诺酮类药物：作用机制、致死性及其对抗生素耐药性的贡献。
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
7
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs).两 decade 成功的 SAR 为基础的 novel 细菌拓扑异构酶抑制剂（NBTIs）的故事。
J Med Chem. 2020 Jun 11;63(11):5664-5674. doi: 10.1021/acs.jmedchem.9b01738. Epub 2020 Feb 17.
8
Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons.结核分枝杆菌gyrase抑制剂的作用机制：一类新型的gyrase毒物
ACS Infect Dis. 2018 Aug 10;4(8):1211-1222. doi: 10.1021/acsinfecdis.8b00035. Epub 2018 May 17.
9
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application.结核病联合治疗的起源：对未来抗菌药物研发与应用的启示
mBio. 2017 Mar 14;8(2):e01586-16. doi: 10.1128/mBio.01586-16.
10
The Halogen Bond.卤键
Chem Rev. 2016 Feb 24;116(4):2478-601. doi: 10.1021/acs.chemrev.5b00484. Epub 2016 Jan 26.